FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

2221000221107: Vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen (medicinal product)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
144591000087112 Varicella-zoster live attenuated vaccine en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
3974560014 Live attenuated Human alphaherpesvirus 3 only vaccine product en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3974561013 Vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen (medicinal product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3974562018 Live attenuated Varicella-zoster vaccine en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3974563011 Live attenuated Human alphaherpesvirus 3 vaccine en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
842421000241113 vaccin vivant atténué contre le virus varicella-zoster fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)


6 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Varicella-zoster live attenuated vaccine Plays role Active immunity stimulant role (role) true Inferred relationship Some
Varicella-zoster live attenuated vaccine Count of base of active ingredient un false Inferred relationship Some
Varicella-zoster live attenuated vaccine a pour principe actif (attribut) Antigen of live attenuated Human alphaherpesvirus 3 (substance) true Inferred relationship Some 1
Varicella-zoster live attenuated vaccine est un(e) (attribut) Human alphaherpesvirus 3 antigen only vaccine product true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Zos ZOSTAVAX MC est un(e) (attribut) False Varicella-zoster live attenuated vaccine Inferred relationship Some
ZOSTAVAX II 19400 plaque forming units per 0.65 milliliter powder and diluent for suspension for injection Merck Canada Inc. (real clinical drug) est un(e) (attribut) False Varicella-zoster live attenuated vaccine Inferred relationship Some
VARILRIX 3300000 plaque forming units per 0.5 milliliter powder and diluent for solution for injection GlaxoSmithKline Inc. (real clinical drug) est un(e) (attribut) False Varicella-zoster live attenuated vaccine Inferred relationship Some
VARIVAX III 1350 plaque forming units powder and diluent for solution for injection Merck Canada Inc. (real clinical drug) est un(e) (attribut) False Varicella-zoster live attenuated vaccine Inferred relationship Some
Administration of live attenuated Human alphaherpesvirus 3 vaccine substance utilisée (attribut) True Varicella-zoster live attenuated vaccine Inferred relationship Some 1
Administration of live attenuated Human alphaherpesvirus 3 vaccine via subcutaneous route substance utilisée (attribut) True Varicella-zoster live attenuated vaccine Inferred relationship Some 1
Vaccine product containing only live attenuated Human alphaherpesvirus 3 Oka strain antigen (medicinal product) est un(e) (attribut) True Varicella-zoster live attenuated vaccine Inferred relationship Some

Reference Sets

Historical name codes for vaccines reference set (foundation metadata concept)

Back to Start